Rhona Finkel

+Rhona Finkel is a health and science writer, covering such topics as mood disorders, technology and health, the plight of the mentally ill, psychiatric medications, and updates and retractions in scientific literature. Also a consultant in social media publicity, she is an author on Candida Abrahamson’s blog at http://candidaabrahamson.wordpress.com.
May 23, 2014

The 5 most profitable medications ever produced

Discover the most profitable drugs ever produced and how they came to be the bestselling medications of all time. Do Viagra, Prozac or Oxycontin make the list?

November 19, 2013

Are medications safe during pregnancy? How are they assessed?

Are medications safe to take during pregnancy? Find out how to assess the risk and why there is so limited information out there for pregnant women.

October 22, 2013

Seeing is Phoning: World Blindness Awareness Month and the Smartphone Revolution

Today, thanks to smartphones, a visually impaired person can walk to the store guided by GPS technology and check out the price of a shirt he wants to buy by scanning its bar code. If he finds it cheaper two blocks away, the app will guide him there, stopping on his way when a large, lovely flower catches his eye. He can snap a shot of it to learn that its color is Alabama crimson. Arriving at the better-priced store, our friend can locate his shirt, bring it to the cashier, and can pay with complete assurance that he is not being cheated.

October 13, 2013

Targeted Therapies and National Breast Cancer Awareness Month

In National Breast Cancer Awareness Month we look at the latest targeted therapies - just one of the reasons for the continued decrease in mortality among breast cancer sufferers.

August 28, 2013

The “Other” Drug Problem

“Drugs don’t work in patients who don’t take them.” Read about medication compliance and its affect on patient outcome. Should patients work harder to comply or are doctors at fault for this?

August 12, 2013

Neiman Marcus Prices for Walmart Healthcare

Everybody loves a bargain, Americans as much as anyone. Yet they have failed to find one in their healthcare system. Let's just take some fairly recent data, published in 2012 by the Organisation for Economic Co-operation and Development (OECD), a group of 34 countries that reports on over 1,200 health system measures. Any guesses here for [...]

July 24, 2013

ZyprexaRelprevv - Till Death Do Us Part

Let's face it.  If the Food and Drug Administration thought it was urgently life–threatening, they would have pulled the drug faster then you can say "ZyprexaRelprevv." But no rational person can honestly interpret the events surrounding June 18, 2013, as positive publicity for drug-maker, Eli Lilly. What in the world is she talking about?You may be [...]

July 8, 2013

NoThing Left Behind - objects left inside patients after surgery!

In a contest nobody wants to win, one Dirk Schroeder seems to have indeed come out victorious. Schroeder went in for a prostate cancer operation in 2009. It seems the operation went well – except for one small thing. Surgeons left not one, not two, not three – but 16 items inside Schroeder's body.   It's [...]

June 30, 2013

The Newest Treatments for Treatment-Resistant Bipolar Depression: Part II, The More Natural Route

So we know from last post that bipolar sufferers spend more time depressed than manic (in a three-to-one ratio), and that with that depression comes lost days per sick worker, a loss to the U.S. labor force in the billions—and the highest suicide rate for any psychiatric disorder.

June 30, 2013

The Newest Treatments for Treatment-Resistant Bipolar Depression: Part I, The Pharmaceuticals

According to the World Health Organization, bipolar disorder is the sixth leading cause of disability in the world. The illness is characterized by periods of overexcitement, or mania, followed by depression, with its reduced functioning. The National Alliance for the Mentally Ill adds the shocking statistic that approximately 25-50% of those with bipolar disorder (BD) attempt [...]

December 14, 2012

Highly-anticipated obesity drugs

In June, the FDA approved the first weight-loss drug in 13 years - Arena Pharmaceuticals Inc's Belviq. Then in July came the approval of Vivus Inc's Qsmyia.

December 5, 2012

Counterfeit Prescription Drugs: How to Protect Yourself

Counterfeit Drugs are those which are deliberately and fraudulently mislabeled with respect to identity and/or source and can apply to both branded and generic products.

Page 1 of 41234